VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the second quarter ended June 30, 2025. Financial Results Business Update Clinical Highlights Jim Corbett, Chief Executive Officer of AVITA Medical, commented: "Although the first half of 2025 tested our resilience and slowed our pace, a resolution is now underway and our strategic direction ...